Page last updated: 2024-10-31

nafamostat and Hypoxia

nafamostat has been researched along with Hypoxia in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.

Research Excerpts

ExcerptRelevanceReference
" However, the effect of nafamostat mesilate (NM), a synthetic serine protease inhibitor, on BBB disruption following cerebral ischemia is unknown."7.83Nafamostat mesilate protects against acute cerebral ischemia via blood-brain barrier protection. ( Chen, T; Fang, Y; Li, C; Liao, H; Pang, T; Shi, X; Wang, J; Zhang, L, 2016)
" However, the effect of nafamostat mesilate (NM), a synthetic serine protease inhibitor, on BBB disruption following cerebral ischemia is unknown."3.83Nafamostat mesilate protects against acute cerebral ischemia via blood-brain barrier protection. ( Chen, T; Fang, Y; Li, C; Liao, H; Pang, T; Shi, X; Wang, J; Zhang, L, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, J1
Li, C1
Chen, T1
Fang, Y1
Shi, X1
Pang, T1
Zhang, L1
Liao, H1

Other Studies

1 other study available for nafamostat and Hypoxia

ArticleYear
Nafamostat mesilate protects against acute cerebral ischemia via blood-brain barrier protection.
    Neuropharmacology, 2016, Volume: 105

    Topics: Animals; Astrocytes; Benzamidines; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Endothelial Cel

2016